A SARS-CoV-2 Omicron outbreak among crew members on a cruise ship in Germany in early 2022

被引:1
|
作者
Buehler, Silja [1 ,2 ,3 ,6 ]
Busch, Philip [1 ]
Wittkamp, Philip [4 ]
Alpers, Katharina [2 ]
Doerre, Achim [2 ]
Plenge-Boenig, Anita [1 ]
Fornacon, Janine [5 ]
Reichstein, Anne [5 ]
Schaefers, Christian [5 ]
Grassl, Birgit [4 ]
Hewelt, Elisabeth [4 ]
Dirksen-Fischer, Martin [4 ]
Kleine-Kampmann, Scarlett [4 ]
机构
[1] Inst Hyg & Environm, Div Hyg & Infect Dis, Hamburg, Germany
[2] Robert Koch Inst, Dept Infect Dis Epidemiol, Postgrad Training Appl Epidemiol, Berlin, Germany
[3] Field Epidemiol Path, European Ctr Dis Prevent & Control Fellowship Prog, Stockholm, Sweden
[4] Hamburg Port Hlth Ctr, Inst Hyg & Environm, Hamburg, Germany
[5] Inst Hyg & Environm, Next Generat Sequencing Lab, Hamburg, Germany
[6] Inst Hyg & Environm, Div Hyg & Infect Dis, Marckmannstr 129a, D-20539 Hamburg, Germany
关键词
crew; cruise ship; Omicron; outbreak; SARS-CoV-2;
D O I
10.5603/imh.96935
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks on cruise ships have rarely been investigated. In early 2022, we were informed about a SARS-CoV-2 outbreak on a cruise ship calling Port of Hamburg after 10 infections among crew members were detected. We conducted an outbreak investigation in collaboration between ship owners, the ship physician and Hamburg's Institute for Hygiene and Environment, to identify risk factors and to achieve containment. The aim was to identify risk factors for SARS-CoV-2 infection and SARS-CoV-2 variants in a cohort of 165 crew members. Materials and methods: For this purpose, we collected data on age, sex, nationality, boarding-time, cabin use (single/shared), work place, and vaccination status of the study participants. Cases were defined as individuals who tested SARS-CoV-2 positive at least once in daily screenings during the outbreak period (10 days) by polymerase chain reaction or antigen test. We investigated risk factors for infection by descriptive, univariable and multivariable analysis. We performed whole genome sequencing to identify SARS-CoV-2 variants. Results: We verified 103 SARS-CoV-2 positive cases (attack rate [AR] 62.4%); 39/41 sequenced samples were BA.2.3 Omicron subtype, one BA.1 and one BA.1.1. Among boostered crew members, AR was 38% vs. 65% among those vaccinated once or twice. Among those who stayed < 30 days on board, AR was 31% vs. 72% among those staying on board longer. Among Europeans, the AR was 53% vs. 71% in non--Europeans.Adjusting for age and sex, cases were more likely to have received no booster vaccine (odds ratio [OR]: 2.66, 95% confidence interval [CI]: 0.99-7.13), to have spent more time on board (>= 30 days, OR: 6.36, 95% CI: 2.81-14.40 vs. < 30 days) and to have a non-European nationality (OR: 2.14, 95% CI: 1.08-4.27). The outbreak stopped shortly after offboard isolation of cases. Conclusions: This investigation confirms the importance of a booster vaccine against COVID-19. Longer stays onboard could facilitate social mixing. Further studies could investigate the impact of social, cultu-ral/behavioural patterns and public health access on the infection risk. Physical distancing together with screening and isolation can contain SARS-CoV-2 outbreaks on cruise ships.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 50 条
  • [41] A SARS-CoV-2 outbreak in a plastics manufacturing plant
    Alice Graham
    Amber I. Raja
    Karin van Veldhoven
    Gillian Nicholls
    Andrew Simpson
    Barry Atkinson
    Ian Nicholls
    Hannah Higgins
    Joan Cooke
    Allan Bennett
    Derek Morgan
    Chris Keen
    Tony Fletcher
    Neil Pearce
    Christina Atchison
    Elizabeth B. Brickley
    Yiqun Chen
    BMC Public Health, 23
  • [42] Projecting the future impact of emerging SARS-CoV-2 variants under uncertainty: Modeling the initial Omicron outbreak
    Moore, Sean
    Cavany, Sean
    Perkins, T. Alex
    Espana, Guido Felipe Camargo
    EPIDEMICS, 2024, 47
  • [43] The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
    Rebecca S. Y. Wong
    SN Comprehensive Clinical Medicine, 2020, 2 (11) : 1983 - 1991
  • [44] Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
    Conklin, Justin
    Arroyo, Jennifer
    Kumar, Rajnish
    Patibandla, Sai
    CLINICAL BIOCHEMISTRY, 2022, 103 : 35 - 36
  • [45] Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil
    de Menezes, Mariane Talon
    Moreira, Filipe Romero Rebello
    Whittaker, Charles
    Santos, Franciele Martins
    Queiroz, Daniel Costa
    Geddes, Victor
    Fonseca, Paula Luize Camargos
    de Jesus, Jaqueline Goes
    Mendes-Oliveira, Franciane
    Reis-Souza, Valquiria
    Santos, Bibiana
    Zauli, Danielle Alves Gomes
    de Lima, Aline Brito
    de Brito Mendonca, Cristiane
    Alvim, Luige Biciati
    Silva, Joice do Prado
    Malta, Frederico Scott Varella
    Ferreira, Alessandro Clayton de Souza
    Faria, Nuno R.
    Sabino, Ester Cerdeira
    Aguiar, Renato Santana
    VIRUSES-BASEL, 2023, 15 (02):
  • [46] Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics
    Meo, S. A.
    Meo, A. S.
    Al-Jassir, F. F.
    Klonoff, D. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (24) : 8012 - 8018
  • [47] Spherical neutralizing aptamer suppresses SARS-CoV-2 Omicron escape
    Sun, Miao
    Wu, Zijing
    Zhang, Jialu
    Chen, Mingying
    Lu, Yao
    Yang, Chaoyong
    Song, Yanling
    NANO TODAY, 2022, 44
  • [48] Mechanistic study of the transmission pattern of the SARS-CoV-2 omicron variant
    An, Ke
    Yang, Xianzhi
    Luo, Mengqi
    Yan, Junfang
    Xu, Peiyi
    Zhang, Honghui
    Li, Yuqing
    Wu, Song
    Warshel, Arieh
    Bai, Chen
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2024, 92 (06) : 705 - 719
  • [49] Across-the-board review on Omicron SARS-CoV-2 variant
    Wasim, Rufaida
    Sumaiya, Asad
    Ahmad, Asad
    INFLAMMOPHARMACOLOGY, 2025, 33 (01) : 1 - 10
  • [50] Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection
    Wu, Yan
    Long, Yiyin
    Wang, Feng
    Liu, Wei
    Wang, Yuliang
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (12)